Regen BioPharma Inc (RGBP)

[cvinvestor]

Yes, good news. I like the fact that the compounds being used in experiments are proprietary, just wish they would fill in a few more details as to who/where the compounds were discovered. Were they part of NCATS partnership, Eli Lilly partnership, somehow in house?

The experiments revealed that administration of Regen's proprietary compounds RG-NA01, RG-NI01 and RG-NI02 prevented cells of the immune system from producing the inflammatory factors interleukin-2, interferon-gamma, tumor necrosis factor-alpha and, importantly, interleukin-17a.

Since both NCATS and Eli Lilly are experiments against other people's existing compounds and the PR states these compounds as proprietary, how did RGBP come about creating/discovering them? Seems like filling in those details could create more interest and prestige for the company.

AIMO

Bought into .13s as once the promo buys are sold and some F&F shares are sold and any dilution shares are sold, this should begin up again as the news is both good and significant for the overall plans of the company. Would seem like some outside entities would want to partner to help fund and accelerate the research and hopefully Koos is willing to do so on decent terms.